These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 36579676)

  • 21. The genetic factors associated with Wnt signaling pathway in colorectal cancer.
    Aghabozorgi AS; Ebrahimi R; Bahiraee A; Tehrani SS; Nabizadeh F; Setayesh L; Jafarzadeh-Esfehani R; Ferns GA; Avan A; Rashidi Z
    Life Sci; 2020 Sep; 256():118006. PubMed ID: 32593708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting lncRNA/Wnt axis by flavonoids: A promising therapeutic approach for colorectal cancer.
    Han S; Cao Y; Guo T; Lin Q; Luo F
    Phytother Res; 2022 Nov; 36(11):4024-4040. PubMed ID: 36227024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin.
    Wu MY; Xie X; Xu ZK; Xie L; Chen Z; Shou LM; Gong FR; Xie YF; Li W; Tao M
    Oncol Rep; 2014 Aug; 32(2):513-22. PubMed ID: 24926961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of non‑coding RNA intertwined with the Wnt/β‑catenin signaling pathway in endometrial cancer (Review).
    Tian Y; Lai T; Li Z; Mao M; Jin Y; Liu Y; Guo R
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37350380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the Wnt signaling pathway in colorectal cancer.
    Sawa M; Masuda M; Yamada T
    Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review).
    Cameselle-García S; Abdulkader-Nallib I; Sánchez-Ares M; Cameselle-Teijeiro JM
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39027989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPER Agonist G1 Prevents Wnt-Induced
    Abancens M; Harvey BJ; McBryan J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt/β‑catenin pathway activation and silencing of the APC gene in HPV‑positive human cervical cancer‑derived cells.
    Ayala-Calvillo E; Mojica-Vázquez LH; García-Carrancá A; González-Maya L
    Mol Med Rep; 2018 Jan; 17(1):200-208. PubMed ID: 29115417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THBS2 promotes cell migration and invasion in colorectal cancer via modulating Wnt/β-catenin signaling pathway.
    Qu HL; Hasen GW; Hou YY; Zhang CX
    Kaohsiung J Med Sci; 2022 May; 38(5):469-478. PubMed ID: 35315209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
    Li Q; Wang G; Tao J; Chen W
    Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.